PENICILLIN G SODIUM

PENICILLIN G SODIUM was reported 1159 times

PENICILLIN G SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INCREASED FOETAL MOVEMENTS 5 0.5556
1 IDIOPATHIC GUTTATE HYPOMELANOSIS 1 0.1111
2 CAPILLARITIS 26 0.0942
3 TOTAL LUNG CAPACITY ABNORMAL 25 0.0643
4 PULMONARY VASCULITIS 27 0.0502
5 MITE ALLERGY 29 0.0443
6 SPIROMETRY ABNORMAL 26 0.0435
7 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 29 0.0396
8 SPLENIC ABSCESS 14 0.0344
9 MYCOTIC ALLERGY 28 0.0327
10 DUST ALLERGY 29 0.0296
11 INCARCERATED UMBILICAL HERNIA 2 0.0233
12 CONJUNCTIVITIS ALLERGIC 28 0.0189
13 NEURITIS 29 0.0188
14 COMPLEMENT FACTOR ABNORMAL 2 0.0187
15 GONORRHOEA 5 0.0185
16 GONOCOCCAL INFECTION 1 0.0145
17 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 29 0.0142
18 GALLBLADDER CANCER METASTATIC 1 0.0141
19 PARVOVIRUS B19 TEST POSITIVE 1 0.0141
20 PHLEBOSCLEROSIS 1 0.0128
21 ACQUIRED TRACHEO-OESOPHAGEAL FISTULA 1 0.0127
22 ENCEPHALITIS FUNGAL 1 0.0111
23 HEPATITIS INFECTIOUS MONONUCLEOSIS 1 0.0103
24 FORCED EXPIRATORY VOLUME DECREASED 29 0.0102
25 ERYTHEMA MIGRANS 1 0.0100
26 NORMOCHROMIC NORMOCYTIC ANAEMIA 29 0.0096
27 RESPIRATORY SYMPTOM 26 0.0091
28 NEPHROSTOMY 3 0.0091
29 GINGIVAL GRAFT 1 0.0088
30 PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS 1 0.0081
31 LOSS OF EMPLOYMENT 22 0.0073
32 SYSTEMIC CANDIDA 17 0.0068
33 SINOBRONCHITIS 1 0.0067
34 DUODENAL OBSTRUCTION 2 0.0067
35 RASH PAPULOSQUAMOUS 1 0.0066
36 VAGINAL CANCER 2 0.0063
37 LYMPH NODE PALPABLE 1 0.0058
38 VEIN PAIN 1 0.0053
39 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 1 0.0053
40 PULMONARY ALVEOLAR HAEMORRHAGE 29 0.0052
41 NEUROLOGICAL SYMPTOM 29 0.0051
42 LUNG DIFFUSION TEST DECREASED 2 0.0050
43 SALPINGO-OOPHORECTOMY BILATERAL 1 0.0050
44 MONONEUROPATHY 1 0.0048
45 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE 1 0.0045
46 GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY 1 0.0045
47 PARANASAL SINUS INFLAMMATION 1 0.0045
48 ARTERIOSCLEROSIS CORONARY ARTERY 29 0.0044
49 LIVER ABSCESS 14 0.0043
50 CHEYNE-STOKES RESPIRATION 1 0.0040
51 DEVICE ALLERGY 1 0.0040
52 CENTRAL NERVOUS SYSTEM VASCULITIS 2 0.0039
53 EPIGLOTTITIS 2 0.0037
54 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 1 0.0034
55 ERYTHROPOIESIS ABNORMAL 1 0.0033
56 EXPOSURE TO ALLERGEN 1 0.0031
57 ARTERIOSCLEROSIS 29 0.0031
58 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
59 ANAESTHESIA 1 0.0027
60 OBSTRUCTIVE AIRWAYS DISORDER 30 0.0027
61 FULL BLOOD COUNT ABNORMAL 28 0.0026
62 MESENTERIC ARTERY THROMBOSIS 1 0.0026
63 VASCULITIC RASH 2 0.0026
64 HEMIANAESTHESIA 2 0.0025
65 NECROTISING ENTEROCOLITIS NEONATAL 1 0.0025
66 RECALL PHENOMENON 2 0.0024
67 THROMBOCYTOPENIA NEONATAL 1 0.0024
68 VASCULITIS 27 0.0023
69 NODULE 30 0.0023
70 HAEMANGIOMA OF SKIN 1 0.0023
71 ALLERGY TEST POSITIVE 1 0.0022
72 ALLERGY TO ARTHROPOD STING 1 0.0022
73 OESOPHAGEAL SPASM 4 0.0022
74 ECZEMA HERPETICUM 1 0.0022
75 LIPASE INCREASED 16 0.0021
76 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
77 LENTIGO 1 0.0020
78 URETEROLITHIASIS 2 0.0019
79 INTRAOCULAR PRESSURE DECREASED 1 0.0019
80 EPHELIDES 1 0.0019
81 TENOSYNOVITIS 5 0.0018
82 PLEOCYTOSIS 1 0.0017
83 NASAL MUCOSAL DISORDER 1 0.0017
84 JUGULAR VEIN THROMBOSIS 3 0.0017
85 DERMO-HYPODERMITIS 1 0.0017
86 HEPATIC STEATOSIS 30 0.0016
87 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 27 0.0016
88 TOXIC SHOCK SYNDROME 1 0.0016
89 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
90 BACILLUS INFECTION 1 0.0016
91 HYPERSENSITIVITY 285 0.0015
92 FORCED VITAL CAPACITY DECREASED 1 0.0015
93 URINE ODOUR ABNORMAL 9 0.0015
94 PULMONARY FIBROSIS 29 0.0015
95 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
96 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
97 JARISCH-HERXHEIMER REACTION 1 0.0014
98 VENOUS INSUFFICIENCY 1 0.0014
99 RUBBER SENSITIVITY 2 0.0013
100 EXTRADURAL ABSCESS 1 0.0013
101 EYELID FUNCTION DISORDER 1 0.0013
102 EMBOLIA CUTIS MEDICAMENTOSA 1 0.0013
103 HEPATITIS VIRAL 1 0.0012
104 SEPSIS NEONATAL 1 0.0012
105 VITAL FUNCTIONS ABNORMAL 1 0.0012
106 ALLERGIC SINUSITIS 1 0.0012
107 KIDNEY FIBROSIS 2 0.0012
108 HAEMOPTYSIS 30 0.0011
109 SKIN TEST POSITIVE 1 0.0011
110 FINGER DEFORMITY 5 0.0010
111 EPIDERMAL NECROSIS 1 0.0010
112 IDIOSYNCRATIC DRUG REACTION 1 0.0010
113 OESOPHAGEAL PAIN 4 0.0010
114 HYPOTHYROIDISM 30 0.0009
115 PRODUCT NAME CONFUSION 1 0.0009
116 PRODUCT SELECTION ERROR 1 0.0009
117 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
118 CANDIDA INFECTION 15 0.0009
119 DILATATION ATRIAL 1 0.0009
120 SINUS PAIN 2 0.0009
121 RESTRICTIVE PULMONARY DISEASE 1 0.0009
122 HYPOXIA 30 0.0009
123 ANAPHYLACTIC REACTION 47 0.0008
124 BREATH ODOUR 2 0.0008
125 APPLICATION SITE SCAR 1 0.0008
126 NECROTISING COLITIS 1 0.0008
127 APGAR SCORE LOW 1 0.0008
128 LIBIDO DISORDER 1 0.0008
129 HEPATITIS TOXIC 2 0.0008
130 TENDON DISORDER 5 0.0008
131 HIRSUTISM 1 0.0008
132 URETERIC OBSTRUCTION 1 0.0007
133 NASAL DISCHARGE DISCOLOURATION 1 0.0007
134 CARPAL TUNNEL SYNDROME 10 0.0007
135 SEBORRHOEIC KERATOSIS 1 0.0007
136 DRUG INTOLERANCE 63 0.0007
137 MEAN CELL VOLUME DECREASED 1 0.0006
138 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
139 CRYPTOCOCCOSIS 1 0.0006
140 CHOLECYSTECTOMY 7 0.0006
141 LUNG DISORDER 30 0.0006
142 PRODUCTIVE COUGH 29 0.0006
143 PULMONARY MASS 9 0.0006
144 PROTEIN URINE PRESENT 3 0.0006
145 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
146 BACTERAEMIA 7 0.0006
147 ENTERITIS INFECTIOUS 1 0.0006
148 LYMPHOEDEMA 4 0.0006
149 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
150 LIVER DISORDER 25 0.0006
151 TETANY 1 0.0005
152 ESSENTIAL HYPERTENSION 1 0.0005
153 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 26 0.0005
154 DENTAL CARE 1 0.0005
155 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0005
156 AUTOIMMUNE THYROIDITIS 2 0.0005
157 HYPOPROTEINAEMIA 1 0.0005
158 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
159 IMMUNE-MEDIATED HEPATITIS 1 0.0005
160 LEG AMPUTATION 2 0.0005
161 SUBILEUS 1 0.0005
162 DERMATITIS ALLERGIC 6 0.0005
163 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
164 WHEEZING 28 0.0005
165 RADIATION PNEUMONITIS 1 0.0005
166 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 33 0.0005
167 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
168 CORNEAL DISORDER 1 0.0005
169 NOSOCOMIAL INFECTION 1 0.0005
170 CLOSTRIDIUM TEST POSITIVE 1 0.0005
171 SUSPECTED OFF LABEL USE 2 0.0004
172 PERIARTHRITIS 1 0.0004
173 SEPTIC SHOCK 19 0.0004
174 OEDEMA 23 0.0004
175 PUSTULE 1 0.0004
176 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
177 PRODUCT PACKAGING CONFUSION 1 0.0004
178 BRONCHITIS CHRONIC 1 0.0004
179 CYSTITIS 13 0.0004
180 DIABETIC NEUROPATHY 2 0.0004
181 INFREQUENT BOWEL MOVEMENTS 1 0.0004
182 URINARY TRACT INFECTION BACTERIAL 1 0.0004
183 HEPATIC CYTOLYSIS 5 0.0004
184 BLOOD CHLORIDE DECREASED 1 0.0004
185 HYPERBILIRUBINAEMIA 4 0.0004
186 CARDIAC FAILURE CONGESTIVE 31 0.0004
187 AREFLEXIA 1 0.0004
188 CARDIAC FAILURE 30 0.0004
189 ULCERATIVE KERATITIS 1 0.0004
190 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
191 RESPIRATORY DISTRESS 10 0.0004
192 PSYCHOMOTOR RETARDATION 1 0.0004
193 PULMONARY EMBOLISM 33 0.0003
194 DYSSTASIA 10 0.0003
195 HEPATIC ENZYME INCREASED 23 0.0003
196 THROMBOSIS 27 0.0003
197 ODYNOPHAGIA 2 0.0003
198 FOETAL GROWTH RESTRICTION 2 0.0003
199 ECTOPIC PREGNANCY 1 0.0003
200 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
201 RESPIRATORY RATE DECREASED 1 0.0003
202 BLEPHAROSPASM 2 0.0003
203 OSTEOPOROSIS 13 0.0003
204 BLADDER PAIN 1 0.0003
205 ABSCESS 5 0.0003
206 PANCREATITIS 16 0.0003
207 TREATMENT FAILURE 25 0.0003
208 CYTOLYTIC HEPATITIS 1 0.0003
209 OLIGOHYDRAMNIOS 1 0.0003
210 SKIN MASS 2 0.0003
211 JOINT RANGE OF MOTION DECREASED 4 0.0003
212 PUSTULAR PSORIASIS 1 0.0003
213 TACHYPHRENIA 1 0.0003
214 BRONCHIOLITIS 1 0.0003
215 PAPULE 2 0.0003
216 NECROTISING FASCIITIS 1 0.0003
217 ASTHMA 32 0.0003
218 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
219 APPARENT DEATH 1 0.0003
220 DERMATITIS BULLOUS 2 0.0003
221 BONE DISORDER 5 0.0003
222 THROMBOCYTOSIS 1 0.0003
223 WOUND HAEMORRHAGE 1 0.0003
224 RASH MACULO-PAPULAR 6 0.0003
225 GASTROINTESTINAL DISORDER 24 0.0003
226 BONE DENSITY ABNORMAL 1 0.0003
227 ACIDOSIS 2 0.0003
228 LEUKOPENIA 13 0.0003
229 REHABILITATION THERAPY 1 0.0003
230 EYELID OEDEMA 3 0.0003
231 APNOEA 2 0.0003
232 POLYDIPSIA 1 0.0003
233 PATENT DUCTUS ARTERIOSUS 1 0.0003
234 ARTHROPATHY 14 0.0003
235 TRIGEMINAL NEURALGIA 1 0.0002
236 CYSTITIS HAEMORRHAGIC 1 0.0002
237 ADVERSE DRUG REACTION 22 0.0002
238 URTICARIA 41 0.0002
239 ANAPHYLACTOID REACTION 1 0.0002
240 SLEEP DISORDER 17 0.0002
241 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
242 LIP OEDEMA 1 0.0002
243 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
244 VITAMIN D DECREASED 2 0.0002
245 EOSINOPHILIA 4 0.0002
246 RESPIRATORY RATE INCREASED 2 0.0002
247 MENINGITIS ASEPTIC 1 0.0002
248 EYE OPERATION 1 0.0002
249 RASH 94 0.0002
250 AGRANULOCYTOSIS 4 0.0002
251 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
252 DISEASE RECURRENCE 10 0.0002
253 SLEEP APNOEA SYNDROME 4 0.0002
254 GASTRIC DISORDER 7 0.0002
255 NASAL POLYPS 1 0.0002
256 ABDOMINAL DISCOMFORT 34 0.0002
257 MUCOUS STOOLS 1 0.0002
258 ABDOMINAL TENDERNESS 1 0.0002
259 VEIN DISORDER 1 0.0002
260 OSTEOPENIA 3 0.0002
261 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
262 DYSLIPIDAEMIA 1 0.0002
263 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
264 BODY TEMPERATURE INCREASED 4 0.0002
265 PHLEBITIS 1 0.0002
266 NEUTROPHIL COUNT INCREASED 2 0.0002
267 SKIN NECROSIS 1 0.0002
268 PARTIAL SEIZURES 1 0.0002
269 BLOOD LACTIC ACID INCREASED 1 0.0002
270 OBESITY 3 0.0002
271 ABDOMINAL PAIN UPPER 38 0.0002
272 INJECTION SITE NODULE 2 0.0002
273 HYPERKERATOSIS 1 0.0002
274 PRODUCT USE ISSUE 34 0.0002
275 STREPTOCOCCAL INFECTION 1 0.0002
276 HYPERTENSION 38 0.0002
277 CHOLECYSTITIS ACUTE 1 0.0002
278 GRANULOCYTOPENIA 1 0.0002
279 HERPES VIRUS INFECTION 1 0.0002
280 ENTEROCOLITIS 1 0.0002
281 ELECTROLYTE IMBALANCE 2 0.0002
282 PRODUCT LABEL CONFUSION 1 0.0002
283 LYMPHOCYTE COUNT DECREASED 3 0.0002
284 DECREASED INTEREST 1 0.0002
285 CONDITION AGGRAVATED 51 0.0002
286 PREMATURE BABY 5 0.0002
287 LEUKOCYTOSIS 3 0.0002
288 RESTLESS LEGS SYNDROME 3 0.0002
289 FIBROMYALGIA 4 0.0002
290 INGUINAL HERNIA 1 0.0002
291 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
292 SWELLING OF EYELID 1 0.0002
293 SKIN EXFOLIATION 13 0.0002
294 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
295 WRONG PRODUCT ADMINISTERED 1 0.0001
296 ANXIETY 42 0.0001
297 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
298 TACHYPNOEA 2 0.0001
299 PALLOR 4 0.0001
300 IMPAIRED GASTRIC EMPTYING 2 0.0001
301 DYSPNOEA 83 0.0001
302 NEPHROTIC SYNDROME 1 0.0001
303 HAIR GROWTH ABNORMAL 1 0.0001
304 ORAL DISCOMFORT 2 0.0001
305 INJURY 10 0.0001
306 DIVERTICULUM 1 0.0001
307 PARALYSIS 2 0.0001
308 MOBILITY DECREASED 10 0.0001
309 PAIN IN EXTREMITY 41 0.0001
310 SWELLING 13 0.0001
311 PARAESTHESIA ORAL 2 0.0001
312 PSYCHIATRIC SYMPTOM 1 0.0001
313 URINARY INCONTINENCE 4 0.0001
314 ORAL PAIN 3 0.0001
315 PEMPHIGOID 1 0.0001
316 ACUTE KIDNEY INJURY 20 0.0001
317 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
318 FOOD ALLERGY 1 0.0001
319 HYPOALBUMINAEMIA 1 0.0001
320 RENAL FAILURE 17 0.0001
321 PULMONARY HAEMORRHAGE 1 0.0001
322 MULTIPLE ALLERGIES 1 0.0001
323 FURUNCLE 1 0.0001
324 PNEUMOTHORAX 2 0.0001
325 TRICUSPID VALVE INCOMPETENCE 1 0.0001
326 ULCER 2 0.0001
327 ATRIAL FLUTTER 1 0.0001
328 SENSORY LOSS 1 0.0001
329 SHOCK HAEMORRHAGIC 1 0.0001
330 METASTASES TO BONE 2 0.0001
331 COUGH 34 0.0001
332 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
333 EOSINOPHIL COUNT INCREASED 1 0.0001
334 ATRIAL SEPTAL DEFECT 1 0.0001
335 FACE OEDEMA 2 0.0001
336 FACIAL PARALYSIS 1 0.0001
337 PSEUDOMONAS INFECTION 1 0.0001
338 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
339 HYSTERECTOMY 1 0.0001
340 PYELONEPHRITIS 1 0.0001
341 METASTASES TO LIVER 2 0.0001
342 HEAD DISCOMFORT 2 0.0001
343 SYNOVITIS 2 0.0001
344 CHILLS 13 0.0001
345 GASTROENTERITIS VIRAL 2 0.0001
346 OROPHARYNGEAL DISCOMFORT 1 0.0001
347 LUPUS-LIKE SYNDROME 1 0.0001
348 PNEUMONITIS 3 0.0001
349 LIP DRY 1 0.0001
350 PELVIC PAIN 2 0.0001
351 C-REACTIVE PROTEIN INCREASED 4 0.0001
352 PATHOGEN RESISTANCE 1 0.0001
353 END STAGE RENAL DISEASE 2 0.0001
354 TINNITUS 5 0.0001
355 JOINT SWELLING 13 0.0001
356 PANCYTOPENIA 6 0.0001
357 FLANK PAIN 1 0.0001
358 BLOOD SODIUM DECREASED 2 0.0001
359 COLITIS 4 0.0001
360 SINUS BRADYCARDIA 1 0.0001
361 DIZZINESS POSTURAL 1 0.0001
362 PHARYNGEAL SWELLING 1 0.0001
363 HEPATOMEGALY 1 0.0001
364 VITREOUS FLOATERS 1 0.0001
365 BRAIN INJURY 1 0.0001
366 CYTOKINE RELEASE SYNDROME 2 0.0001
367 CELLULITIS 5 0.0001
368 FEEDING DISORDER 2 0.0001
369 BONE MARROW FAILURE 2 0.0001
370 DRY THROAT 1 0.0001
371 MOTOR DYSFUNCTION 1 0.0001
372 INJECTION SITE RASH 3 0.0001
373 TEMPERATURE INTOLERANCE 1 0.0001
374 POOR VENOUS ACCESS 1 0.0001
375 DRUG-INDUCED LIVER INJURY 3 0.0001
376 OSTEOARTHRITIS 4 0.0001
377 RENAL PAIN 1 0.0001
378 MALAISE 41 0.0001
379 PHARYNGITIS STREPTOCOCCAL 1 0.0001
380 ANGIOEDEMA 4 0.0001
381 MALNUTRITION 1 0.0001
382 NEPHROPATHY TOXIC 1 0.0001
383 ARTHRALGIA 37 0.0001
384 BLOOD CALCIUM DECREASED 1 0.0001
385 HYPONATRAEMIA 5 0.0001
386 DERMATITIS CONTACT 1 0.0001
387 SHOCK 2 0.0001
388 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
389 LYMPHADENOPATHY 3 0.0001
390 BLOOD IRON DECREASED 1 0.0001
391 CHOLECYSTITIS 1 0.0001
392 ACCIDENT 1 0.0001
393 RASH ERYTHEMATOUS 4 0.0001
394 RENAL IMPAIRMENT 7 0.0001
395 MYELOSUPPRESSION 3 0.0001
396 RESPIRATORY FAILURE 6 0.0001
397 CEREBRAL INFARCTION 2 0.0001
398 RESPIRATORY DEPRESSION 1 0.0001
399 DYSURIA 3 0.0001
400 BRONCHITIS 6 0.0001
401 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
402 THROMBOCYTOPENIA 9 0.0001
403 ILEUS 1 0.0001
404 SECRETION DISCHARGE 1 0.0001
405 DYSPNOEA EXERTIONAL 3 0.0001
406 MUSCLE ATROPHY 1 0.0001
407 FLUID RETENTION 4 0.0001
408 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
409 HYPERHIDROSIS 10 0.0001
410 PLATELET COUNT INCREASED 1 0.0001
411 DRUG INEFFECTIVE 101 0.0001
412 BLOOD CREATININE INCREASED 5 0.0001
413 GASTRITIS 2 0.0001
414 OEDEMA PERIPHERAL 9 0.0001
415 LIMB INJURY 2 0.0001
416 MIGRAINE 7 0.0001
417 GINGIVAL BLEEDING 1 0.0001
418 HEADACHE 45 0.0001
419 CARDIO-RESPIRATORY ARREST 3 0.0001
420 COORDINATION ABNORMAL 1 0.0001
421 BLISTER 4 0.0001
422 SKIN REACTION 1 0.0001
423 LYMPHOPENIA 1 0.0001
424 SINUS TACHYCARDIA 1 0.0001
425 BRONCHOSPASM 1 0.0001
426 CARDIOGENIC SHOCK 1 0.0001
427 PANCREATIC CARCINOMA 2 0.0001
428 VAGINAL HAEMORRHAGE 3 0.0001
429 ANOSMIA 1 0.0001
430 FLUID OVERLOAD 1 0.0001
431 CHEST DISCOMFORT 7 0.0001
432 AGITATION 5 0.0001
433 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
434 BONE LOSS 1 0.0001
435 STOMATITIS 4 0.0001
436 VISION BLURRED 9 0.0001
437 SKIN IRRITATION 3 0.0001
438 FEELING HOT 4 0.0001
439 PHARYNGEAL OEDEMA 1 0.0001
440 PERIPHERAL SWELLING 10 0.0001
441 NAUSEA 51 0.0001
442 SWOLLEN TONGUE 2 0.0001
443 DIARRHOEA 41 0.0001
444 PREMATURE DELIVERY 1 0.0001
445 SCIATICA 1 0.0001
446 METABOLIC ACIDOSIS 2 0.0001
447 PRURITUS 24 0.0001
448 INFECTION 9 0.0001
449 NIGHT SWEATS 2 0.0001
450 OFF LABEL USE 54 0.0001
451 BLOOD POTASSIUM INCREASED 1 0.0001
452 HEART RATE INCREASED 6 0.0001
453 PHOTOSENSITIVITY REACTION 1 0.0001
454 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
455 LIP SWELLING 2 0.0001
456 COAGULOPATHY 1 0.0001
457 SKIN DISORDER 2 0.0001
458 GAIT INABILITY 2 0.0001
459 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
460 URINARY TRACT INFECTION 10 0.0001
461 SCAR 1 0.0001
462 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
463 PARANOIA 1 0.0001
464 ORTHOSTATIC HYPOTENSION 1 0.0001
465 ECZEMA 3 0.0001
466 MUSCULOSKELETAL PAIN 3 0.0001
467 RASH MACULAR 2 0.0001
468 DEVICE USE ISSUE 1 0.0001
469 DEPRESSED MOOD 3 0.0001
470 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
471 DRUG ERUPTION 1 0.0001
472 TACHYCARDIA 5 0.0001
473 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
474 GALLBLADDER DISORDER 1 0.0001
475 THIRST 1 0.0001
476 GOUT 1 0.0001
477 RASH PRURITIC 3 0.0001
478 OSTEOMYELITIS 1 0.0001
479 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
480 RESTLESSNESS 2 0.0001
481 FEELING ABNORMAL 13 0.0001
482 WEIGHT DECREASED 15 0.0001
483 PAIN 33 0.0001
484 MIDDLE INSOMNIA 1 0.0001
485 HEPATIC CIRRHOSIS 1 0.0001
486 PHOTOPHOBIA 1 0.0001
487 HALLUCINATION 4 0.0001
488 HYPOCALCAEMIA 1 0.0001
489 BLOOD URINE PRESENT 1 0.0001
490 GASTRIC ULCER 1 0.0001
491 PROTEINURIA 1 0.0001
492 MUSCULOSKELETAL DISORDER 1 0.0001
493 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
494 HERPES ZOSTER 3 0.0001
495 CHOLESTASIS 1 0.0001
496 PYREXIA 18 0.0001
497 PALPITATIONS 6 0.0001
498 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
499 SINUS DISORDER 1 0.0001
500 HAEMATOCRIT DECREASED 1 0.0001
501 PRODUCT PHYSICAL ISSUE 1 0.0000
502 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
503 BLINDNESS 2 0.0000
504 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
505 PERITONITIS 1 0.0000
506 ABDOMINAL DISTENSION 5 0.0000
507 ABDOMINAL PAIN 11 0.0000
508 JOINT INJURY 1 0.0000
509 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
510 SWELLING FACE 3 0.0000
511 PSORIASIS 6 0.0000
512 STEVENS-JOHNSON SYNDROME 1 0.0000
513 TOOTH DISORDER 1 0.0000
514 SNEEZING 1 0.0000
515 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
516 NEPHROLITHIASIS 2 0.0000
517 SKIN DISCOLOURATION 2 0.0000
518 MUSCLE TWITCHING 1 0.0000
519 PNEUMONIA 14 0.0000
520 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
521 OCULAR HYPERAEMIA 2 0.0000
522 COMA 2 0.0000
523 LOCALISED INFECTION 1 0.0000
524 MYALGIA 7 0.0000
525 LIVER INJURY 1 0.0000
526 ENCEPHALOPATHY 1 0.0000
527 DYSPEPSIA 4 0.0000
528 VOMITING 19 0.0000
529 EPISTAXIS 3 0.0000
530 AGEUSIA 1 0.0000
531 HYPOAESTHESIA 6 0.0000
532 HYPOPHAGIA 1 0.0000
533 HOSPITALISATION 6 0.0000
534 DRUG RESISTANCE 1 0.0000
535 ILLNESS 4 0.0000
536 ANAPHYLACTIC SHOCK 1 0.0000
537 UNRESPONSIVE TO STIMULI 1 0.0000
538 RASH GENERALISED 1 0.0000
539 FEAR 1 0.0000
540 JAUNDICE 1 0.0000
541 THROAT TIGHTNESS 1 0.0000
542 SKIN LESION 1 0.0000
543 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
544 HAEMATOCHEZIA 2 0.0000
545 DIVERTICULITIS 1 0.0000
546 MENTAL STATUS CHANGES 1 0.0000
547 INFLUENZA 4 0.0000
548 OXYGEN SATURATION DECREASED 2 0.0000
549 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
550 HYPERSOMNIA 1 0.0000
551 LETHARGY 2 0.0000
552 FATIGUE 27 0.0000
553 DECREASED APPETITE 8 0.0000
554 NEEDLE ISSUE 1 0.0000
555 DYSPHONIA 2 0.0000
556 CATARACT 2 0.0000
557 HEPATIC FAILURE 1 0.0000
558 VERTIGO 2 0.0000
559 EPILEPSY 1 0.0000
560 BLOOD PRESSURE INCREASED 5 0.0000
561 OROPHARYNGEAL PAIN 3 0.0000
562 NERVOUS SYSTEM DISORDER 1 0.0000
563 BONE DENSITY DECREASED 1 0.0000
564 ANAEMIA 6 0.0000
565 MOOD SWINGS 1 0.0000
566 CONTUSION 3 0.0000
567 DEPRESSION 7 0.0000
568 CHOLELITHIASIS 1 0.0000
569 EYE DISORDER 1 0.0000
570 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
571 FEBRILE NEUTROPENIA 2 0.0000
572 BACK PAIN 7 0.0000
573 BLOOD PRESSURE DECREASED 2 0.0000
574 FUNGAL INFECTION 1 0.0000
575 SYNCOPE 3 0.0000
576 URINARY RETENTION 1 0.0000
577 SOMNOLENCE 6 0.0000
578 TYPE 2 DIABETES MELLITUS 1 0.0000
579 ANGER 1 0.0000
580 FLUSHING 3 0.0000
581 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
582 ASTHENIA 11 0.0000
583 HAEMOGLOBIN DECREASED 3 0.0000
584 ERYTHEMA 6 0.0000
585 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
586 INJECTION SITE REACTION 2 0.0000
587 DIZZINESS 14 0.0000
588 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
589 HYPERGLYCAEMIA 1 0.0000
590 SEPSIS 3 0.0000
591 HEPATIC FUNCTION ABNORMAL 1 0.0000
592 WEIGHT INCREASED 6 0.0000
593 DYSARTHRIA 1 0.0000
594 HOT FLUSH 2 0.0000
595 UNEVALUABLE EVENT 2 0.0000
596 MUSCULAR WEAKNESS 3 0.0000
597 PARAESTHESIA 4 0.0000
598 DISORIENTATION 1 0.0000
599 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
600 DRY MOUTH 2 0.0000
601 NEUTROPHIL COUNT DECREASED 1 0.0000
602 CARDIAC ARREST 2 0.0000
603 POLLAKIURIA 1 0.0000
604 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
605 MENTAL DISORDER 1 0.0000
606 MYOCARDIAL INFARCTION 4 0.0000
607 CONSTIPATION 5 0.0000
608 MUSCULOSKELETAL STIFFNESS 2 0.0000
609 DEHYDRATION 3 0.0000
610 PULMONARY OEDEMA 1 0.0000
611 SUICIDAL IDEATION 2 0.0000
612 HYPOKALAEMIA 1 0.0000
613 CHEST PAIN 4 0.0000
614 BLOOD CHOLESTEROL INCREASED 1 0.0000
615 COGNITIVE DISORDER 1 0.0000
616 CARDIAC DISORDER 2 0.0000
617 DYSPHAGIA 2 0.0000
618 BLOOD GLUCOSE DECREASED 1 0.0000
619 INTERSTITIAL LUNG DISEASE 1 0.0000
620 DRY EYE 1 0.0000
621 HYPOTENSION 4 0.0000
622 DEATH 17 0.0000
623 INJECTION SITE PAIN 6 0.0000
624 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
625 NERVOUSNESS 1 0.0000
626 BRADYCARDIA 1 0.0000
627 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
628 CONFUSIONAL STATE 3 0.0000
629 DISTURBANCE IN ATTENTION 1 0.0000
630 MEDICATION ERROR 1 0.0000
631 CEREBROVASCULAR ACCIDENT 3 0.0000
632 FLATULENCE 1 0.0000
633 CONVULSION 1 0.0000
634 EYE IRRITATION 1 0.0000
635 THERAPEUTIC RESPONSE DECREASED 1 0.0000
636 SUICIDE ATTEMPT 1 0.0000
637 PLEURAL EFFUSION 1 0.0000
638 DISCOMFORT 1 0.0000
639 EXPOSURE DURING PREGNANCY 1 0.0000
640 DEVICE EXPULSION 1 0.0000
641 DEVICE DIFFICULT TO USE 1 0.0000
642 DRY SKIN 2 0.0000
643 INJECTION SITE PRURITUS 1 0.0000
644 NEUTROPENIA 2 0.0000
645 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
646 THERAPY INTERRUPTED 1 0.0000
647 SKIN BURNING SENSATION 1 0.0000
648 DYSGEUSIA 1 0.0000
649 INCORRECT DOSE ADMINISTERED 3 0.0000
650 INJECTION SITE SWELLING 1 0.0000
651 ARTHRITIS 1 0.0000
652 DRUG INTERACTION 2 0.0000
653 DRUG ABUSE 1 0.0000
654 TOXICITY TO VARIOUS AGENTS 2 0.0000
655 BALANCE DISORDER 1 0.0000
656 INTENTIONAL PRODUCT MISUSE 1 0.0000
657 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
658 COVID-19 2 0.0000
659 DRUG WITHDRAWAL SYNDROME 1 0.0000
660 INSOMNIA 3 0.0000
661 DEVICE ISSUE 1 0.0000
662 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
663 NO ADVERSE EVENT 2 0.0000
664 ADVERSE EVENT 1 0.0000
665 NASOPHARYNGITIS 2 0.0000
666 BLOOD GLUCOSE INCREASED 2 0.0000
667 NEUROPATHY PERIPHERAL 1 0.0000
668 GAIT DISTURBANCE 2 0.0000
669 ATRIAL FIBRILLATION 1 0.0000
670 SINUSITIS 1 0.0000
671 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
672 HAEMORRHAGE 1 0.0000
673 PLATELET COUNT DECREASED 1 0.0000
674 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
675 FALL 3 0.0000
676 RHEUMATOID ARTHRITIS 1 0.0000
677 SEIZURE 1 0.0000
678 DISEASE PROGRESSION 1 0.0000
679 VISUAL IMPAIRMENT 1 0.0000
680 INJECTION SITE ERYTHEMA 1 0.0000
681 LOSS OF CONSCIOUSNESS 1 0.0000
682 PRODUCT DOSE OMISSION ISSUE 2 0.0000
683 TREMOR 1 0.0000
684 MUSCLE SPASMS 1 0.0000
685 ALOPECIA 1 0.0000